SB 11285

· invoX Pharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB 11285, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors [Phase 1]

See pricing